Viz.ai and Avicenna.AI Launch AI-Driven Intelligent Care Coordination for PE and Aortic Disease

July 15, 2021—Viz.ai announced it has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients with pulmonary embolism (PE) and aortic disease. The collaboration seeks to apply artificial intelligence (AI) to provide faster clinical decision-making and care for patients with these conditions.

According to the announcement, Avicenna.AI’s FDA-cleared algorithms for PE and type A and type B aortic dissection, leveraged on the Viz.ai intelligent care coordination platform, will enable multidisciplinary teams to coordinate patient care by sending notifications paired with dynamic imaging and detailed patient information to each provider’s desktop or mobile device as soon as a PE or aortic dissection is detected.

As part of Viz.ai’s commercial aortic module offering, access to imaging and workflows supporting the coordination of care for patients with abdominal aortic aneurysm, thoracic aortic aneurysm, rupture, stenosis, and transection will be available in addition to the aortic dissection algorithm. Similarly, the PE algorithm will be available on Viz.ai’s commercial PE module.

Richard Saxon, MD, an interventional radiologist at Tri-City Medical Center in San Diego, California, commented in the company’s press release, “The addition of AI-powered workflows should decrease the time from diagnosis to treatment and help to coordinate care for patients suffering from life-threatening PE and aortic disease, as it has in the treatment of ischemic stroke. It will help to facilitate faster and easier treatment decisions across health systems, and this should improve outcomes for patients.”

The company stated that the Viz platform is proven to save time and improve patient outcomes, and that pairing team alerts enhanced by AI with high-fidelity mobile image viewing, patient information, and full-stack secure communication enables multidisciplinary teams to make faster treatment decisions for patients. In 2020, CMS granted Viz.ai a New Technology Add-on Payment for the stroke module, Viz LVO.